Siemens Healthineers AG Stock

Equities

SHL

DE000SHL1006

Advanced Medical Equipment & Technology

Market Closed - Xetra 11:35:11 2024-04-26 EDT 5-day change 1st Jan Change
52.94 EUR +1.22% Intraday chart for Siemens Healthineers AG +4.21% +0.65%

Financials

Sales 2024 * 22.75B 24.32B 33.25B Sales 2025 * 24.34B 26.02B 35.57B Capitalization 59.07B 63.16B 86.34B
Net income 2024 * 2.05B 2.19B 3B Net income 2025 * 2.58B 2.75B 3.77B EV / Sales 2024 * 3.11 x
Net Debt 2024 * 11.7B 12.51B 17.11B Net Debt 2025 * 10.34B 11.05B 15.11B EV / Sales 2025 * 2.85 x
P/E ratio 2024 *
28.9 x
P/E ratio 2025 *
23 x
Employees 71,400
Yield 2024 *
1.94%
Yield 2025 *
2.39%
Free-Float 23.56%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Siemens Healthineers AG

1 day+1.22%
1 week+4.21%
Current month-6.66%
1 month-4.27%
3 months+1.85%
6 months+14.81%
Current year+0.65%
More quotes
1 week
50.90
Extreme 50.9
53.26
1 month
49.74
Extreme 49.74
56.94
Current year
49.74
Extreme 49.74
58.14
1 year
44.39
Extreme 44.39
58.14
3 years
40.32
Extreme 40.32
67.66
5 years
28.50
Extreme 28.5
67.66
10 years
28.50
Extreme 28.5
67.66
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 17-12-31
Director of Finance/CFO 57 17-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 64 22-10-31
Director/Board Member 57 21-03-22
Director/Board Member 71 18-02-28
More insiders
Date Price Change Volume
24-04-26 52.94 +1.22% 700,939
24-04-25 52.3 -0.87% 646,680
24-04-24 52.76 +1.15% 812,160
24-04-23 52.16 +1.36% 646,632
24-04-22 51.46 +1.30% 673,072

Delayed Quote Xetra, April 26, 2024 at 11:35 am

More quotes
Siemens Healthineers AG is one of the world's No.1 manufacturers of equipment for medical imaging, laboratory diagnostics and hospital information systems. In addition, the group is developing digital health services and services dedicated to health establishments. Net sales break down by activity as follows: - sale of imaging equipment and solutions (53%); - sale of diagnostic equipment (21%); - sale of solutions and services for cancer care (16.6%); - sale of advanced therapeutic solutions (9.4%): for image-guided minimally invasive treatments in the areas of cardiology, interventional radiology and surgery. Net sales are distributed geographically as follows: Germany (4.9%), Europe/CIS/Africa/Middle East (27.3%), the United States (34.6%), America (6.3%), China (13%) and Asia/Pacific and Japan (13.9%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
52.94 EUR
Average target price
60.33 EUR
Spread / Average Target
+13.96%
Consensus